Durect(us:DRRX)
0.8020
0.00%
Updated on 2025-04-02
Open:0.8000
Close:0.8020
High:0.8049
Low:0.8000
Prev Close:0.8020
Volume:46499.00
Turnover:37233.62
Turnover Ratio:0.15%
Shares:31.04M
MarketCap:24.90M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 49 | 7522636 | 24.24% | 9 | 14 | 14 |
| 2024-03-31 | 53 | 6940827 | 22.36% | 5 | 12 | 26 |
| 2023-12-31 | 65 | 6813579 | 22.46% | 13 | 11 | 31 |
| 2023-09-30 | 64 | 9631808 | 33.77% | 9 | 17 | 20 |
| 2023-06-30 | 65 | 9062503 | 36.83% | 10 | 12 | 28 |
| 2023-03-31 | 61 | 9959970 | 40.68% | 5 | 20 | 17 |
| 2022-12-31 | 81 | 9297135 | 40.80% | 9 | 15 | 46 |
| 2022-09-30 | 91 | 94963496 | 41.69% | 4 | 14 | 43 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Ingalls & Snyder Llc | 2016622 | 6.50% | -129380 | -6.03% |
| 2024-03-31 | Vanguard Group Inc | 1080256 | 3.48% | 7767 | 0.72% |
| 2024-03-31 | Richmond Brothers, Inc. | 768344 | 2.48% | 250050 | 48.24% |
| 2024-03-31 | Gagnon Securities Llc | 380131 | 1.22% | 21425 | 5.97% |
| 2024-03-31 | Blackrock Inc. | 344275 | 1.11% | 5420 | 1.60% |
| 2024-03-31 | Geode Capital Management, Llc | 293150 | 0.94% | 58786 | 25.08% |
| 2024-03-31 | Beirne Wealth Consulting Services, Llc | 283008 | 0.91% | -37043 | -11.57% |
| 2024-03-31 | Montchanin Asset Management, Llc | 270101 | 0.87% | 154659 | 133.97% |
| 2024-03-31 | Tocqueville Asset Management L.P. | 256220 | 0.83% | 25000 | 10.81% |
| 2024-03-31 | Gsa Capital Partners Llp | 241669 | 0.78% | 241669 |
About
DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.
Address:10240 Bubb Road
Website:http://www.durect.com
Market Movers